Home Tags Araris Biotech

Tag: Araris Biotech

Araris Biotech and Taiho Pharmaceutical to Jointly Develop Next-Generation ADCs

Swiss oncology-focused Araris Biotech, a spin-off company from the Paul Scherrer Institute (PSI) and ETH Zurich, which is pioneering the development of next generation, proprietary antibody-drug conjugate (ADC)-linker technology, has entered a collaboration agreement with Japanese R&S driven specialty pharma Taiho Pharmaceutical Co.

AACR 2023: Preclinical Data Highlights Stable and Efficacious Low Drug-Load ADCs

Two poster presentations at the American Association for Cancer Research (AACR) 2023 Annual Meeting, being held April 14-19, 2023 at the Orange County Convention Center in Orlando, Florida, highlight late-breaking preclinical data from studies with an anti-Nectin-4 ADC and anti-HER2 ADC.